| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7503109 | Drug and Alcohol Dependence | 2018 | 8 Pages |
Abstract
The findings support clinical tolerability and safety and suggest potential efficacy of atomoxetine for treating ATS use disorder in this population.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Richard S. Schottenfeld, Marek C. Chawarski, Mehmet Sofuoglu, Weng-Tink Chooi, Norzarina M. Zaharim, M. Azhar M. Yasin, Imran Ahmad, Sharifah Zubaidiah Syed Jaapar, Vicknasingam B. Kasinather,